Biotech Analyst Watsek and Biopharma & Biotech Analysts Chen & Kim, along with Dr. Moscol, Assistant Professor, University of Texas MD Anderson Cancer Center, discuss recent developments and debates on oral SERDs and PROTAC Degraders in breast cancer on an Analyst/Industry conference call to be held on January 30 at 11 am. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on PFE:
- Pharma Industry Could Benefit from Rise in Medicine Spending
- Seven Stocks to Buy Before Their Ex-Dividend Dates Arrive
- Moderna price target raised to $111 from $102 at SVB Securities
- Arvinas price target lowered to $65 from $100 at Truist
- Pfizer downgraded to Equal Weight from Overweight at Wells Fargo
